University Health Network, Toronto: Uterine Cervical Neoplasms trials
The registry lists 18 Uterine Cervical Neoplasms studies with University Health Network, Toronto as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 7No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing SurgeryRecruitingNCT04016389Not applicable
- FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)RecruitingNCT03853915Not applicable
- Cervical Ca PROs in Clinical PracticeCompletedNCT03048435
- Sentinel Lymph Node Detection in Early Cervical CancerCompletedNCT02543775Not applicable
- The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized TrialCompletedNCT02394652Phase 2
- MRI FDG PET Imaging CervixCompletedNCT01899404Not applicable
- Cervix Hypoxia FAZAActive, not recruitingNCT01549730Not applicable
- Predictive Assays In Cervix CancerActive, not recruitingNCT01181375Not applicable
- Intra-Pelvic Organ Motion for Cervix Cancer Patient Using ImagingActive, not recruitingNCT00957450
- Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix CancerCompletedNCT00938106Phase 2
- Pap Smear Research StudyCompletedNCT00743626Not applicable
- A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical CancerCompletedNCT00510250Phase 1/2
- Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance TechniquesCompletedNCT00242034Not applicable
- Combidex USPIO - Ultra-small Superparamagnetic Iron OxideCompletedNCT00188695Phase 1/2
- Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)CompletedNCT00188578Phase 1/2
- Cervix: Hypoxia, Interstitial Fluid Pressure and GSH LevelsActive, not recruitingNCT00188539Phase 2
- Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the CervixCompletedNCT00152828Phase 1/2
- EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1